Oral semaglutide hasn't shifted prescribing as expected. Shawn Davis, MD, discusses what access and policy changes are needed to close the coverage gap.
Shawn Davis, MD
Advertisement
Shawn Davis, MD, is a physician specializing in obesity medicine at Kelsey-Seybold Clinic
Articles by Shawn Davis, MD
With obesity costing $1.4 trillion annually, Shawn Davis, MD, argues the return on treatment investment is clear if we build systems to measure it.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
2
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
3
ATTR-CM Incidence, Prevalence Rose Sharply in the US
4
Switch to Ocrelizumab Shows Safety in Patients With Relapsing MS
5